tradingkey.logo

Prophase Labs Inc

PRPH
查看详细走势图
0.615USD
-0.072-10.48%
收盘 12/24, 13:00美东报价延迟15分钟
2.55M总市值
亏损市盈率 TTM

Prophase Labs Inc

0.615
-0.072-10.48%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-10.48%

5天

+485.71%

1月

+241.67%

6月

+75.71%

今年开始到现在

-18.77%

1年

-2.38%

查看详细走势图

TradingKey Prophase Labs Inc股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Prophase Labs Inc当前公司基本面数据相对谨慎,增长潜力稳定。当前估值合理,在医疗服务供应商行业排名70/78位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价16.00。中期看,股价处于上升通道。近一个月,市场表现很强,技术面评分较高,但很强的走势得没有得到基本面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Prophase Labs Inc评分

相关信息

行业排名
70 / 78
全市场排名
459 / 4562
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
16.000
目标均价
+5111.73%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Prophase Labs Inc亮点

亮点风险
ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.
业绩增长期
公司处于发展阶段,最新年度总收入6.77M美元
估值高估
公司最新PE估值-0.03,处于3年历史高位
机构减仓
最新机构持股3.04M股,环比减少45.19%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值53.19K
活跃度增加
近期活跃度增加,过去20天平均换手率4.02

Prophase Labs Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Prophase Labs Inc简介

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.
公司代码PRPH
公司Prophase Labs Inc
CEOKarkus (Ted William)
网址https://www.prophaselabs.com/

常见问题

Prophase Labs Inc(PRPH)的当前股价是多少?

Prophase Labs Inc(PRPH)的当前股价是 0.615。

Prophase Labs Inc的股票代码是什么?

Prophase Labs Inc的股票代码是PRPH。

Prophase Labs Inc股票的52周最高点是多少?

Prophase Labs Inc股票的52周最高点是9.349。

Prophase Labs Inc股票的52周最低点是多少?

Prophase Labs Inc股票的52周最低点是0.639。

Prophase Labs Inc的市值是多少?

Prophase Labs Inc的市值是2.55M。

Prophase Labs Inc的净利润是多少?

Prophase Labs Inc的净利润为-53.36M。

现在Prophase Labs Inc(PRPH)的股票是买入、持有还是卖出?

根据分析师评级,Prophase Labs Inc(PRPH)的总体评级为--,目标价格为16.000。

Prophase Labs Inc(PRPH)股票的每股收益(EPS TTM)是多少

Prophase Labs Inc(PRPH)股票的每股收益(EPS TTM)是-17.761。
KeyAI